The Combination of Radiotherapy and Chemotherapy: A Review

References

• Armand J.P., Rahal M., Azli N., Wibault P., Schwaab G., Boussen H., Bachouchi M., Wendling J.L., Cvitkovic E. Alternating chemo-radiotherapy (CT-RT) in undifferentiated carcinoma nasopharyngeal type (UCNT) with advanced (N3) nodal disease. Proceedings of American Society of Clinical Oncology 1988; 7: 151–151, (abstract 586).
   Google Scholar
• Arriagada R., Le Chevalier T., Baldeyrou P., Pico J.L., Ruffie P., Martin M., El Bakry H.M., Duroux P., Bignon J., Lenfant B., Hayat M., Rouesse J.G., Sancho-Garnier H., Tubiana M. Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 1461–1467
   PubMedGoogle Scholar
• Arriagada, R., Mouriesse, H., Sarrazin, D., et al. Radiotherapy alone in breast cancer. Analysis of tumor parameters, tumor dose and local control. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 1751–1757
   PubMed Web of Science ®Google Scholar
• Bonadonna G., Valagussa P., Rossi A., Tancini G., Brambilla C., Zambetti M., Veronesi U. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Research Treatment 1985; 5: 95–115
   PubMed Web of Science ®Google Scholar
• Brooks B.J., Jr., Seifter E.J., Walsh T.E., Lichter A.S., Bunn P.A., Zabell A., Johnston-Early A., Edison M., Makuch R.W., Cohen M.H., Glatstein E., Ihde D.C. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. Journal of Clinical Oncology 1986; 4: 200–209
   PubMed Web of Science ®Google Scholar
• Bunn P.A., Lichter A.S., Makuch R.W., Cohen M.H., Veach S.R., Matthews M.J., Anderson A.J., Edison M., Glatsein E., Minna J.D., Ihde D.C. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer: a prospective randomized trial. Annals of Internal Medicine 1987; 106: 655–662
   PubMed Web of Science ®Google Scholar
• Carde P., Burgers J.M.V., Henry-Amar M., Hayat M., Sizoo W., Van der Schueren E., Monconduit M., Noordijk E.M., Lustman-Marechal J., Tanguy A., De Pauw B., Cosset J.M., Cattan A., Schneider M., Thomas J., Meerwaldt J.H., Somers R., Tubiana M. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors. Journal of Clinical Oncology 1988; 6: 239–252
   PubMed Web of Science ®Google Scholar
• Choi N.C., Propert K., Carey R.W., Eaton W., Leone L.A., Silberfarb P., Green M. Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II study of cancer and Leukemia Group B. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 263–266
   PubMedGoogle Scholar
• Cohen M.H. Is thoracic radiation therapy necessary for patients with limited-stage small cell lung cancer? No. Cancer Treatment Reports 1983; 67: 217–221
   PubMedGoogle Scholar
• Cosset J.M., Ozanne F., Henry Amar M., Carde P., Amiel J.L., Hayat M., Habrand J.L., Tubiana M. An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results. Radiotherapy and Oncology 1985; 3: 133–138
   PubMed Web of Science ®Google Scholar
• DeVita V.T., Lippman M., Hubbard S.M., Ihde D.C., Rosenberg S.A. The effect of combined modality therapy on local control and survival. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 487–501
   PubMedGoogle Scholar
• Dutreix J., Tubiana M., Dutreix A. An approach to the interpretation of clinical data on the tumor control probability-dose relationship. Radiotherapy and Oncology 1988; 11: 239–248
   PubMed Web of Science ®Google Scholar
• Ensley J.F., Jacobs J.R., Weaver A., Kinzie J., Crissman J., Kish J.A., Cummings G., Al-Sarraf M. Correlation between response to cis-platinum combination and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 1984; 54: 811–814
   PubMed Web of Science ®Google Scholar
• Fisher, B., Bauer, M., Margolese, R., et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. New England Journal of Medicine 1985; 312: 665–673
   PubMed Web of Science ®Google Scholar
• Fu K.K. Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 1985; 55: 2123–2130
   PubMed Web of Science ®Google Scholar
• Goldie G.H., Coldman A.G. The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Research 1984; 44: 3643–3663
   PubMed Web of Science ®Google Scholar
• Gore, S.M., Come, S.M., Rose, M.A., et al. Influence of the sequencing of chemotherapy and radiation therapy in node-negative breast cancer patients treated by conservative surgery and radiation therapy. Adjuvant Therapy of Cancer, S.E. Salmon. Grune & Stratton, Orlando 1987; 5: 365–373
   Google Scholar
• Guiguet M., Koscielny S., Valleron A.J., Tubiana M. Estimation par un modèle de simulation de la taille maximale des nodules métastatiques guéris par une thérapie adjuvante. Neo-Adjuvant Chemotherapy, C. Jacquillat, M. Weil, D. Khayat. J. Libbey, Paris 1986; 137: 825–833, Colloque INSERM
   Google Scholar
• Haie C., George M., Pejovic M.H., Chassagne D., Gerbaulet A., Horiot J.C., Fenton J., Le Floch O., Heron J.F. Feasibility study of an alternating schedule of radiotherapy and chemotherapy in advanced uterine cervical carcinoma. Radiotherapy and Oncology 1988; 12: 121–127
   PubMedGoogle Scholar
• Hill B.T., Whelan R.D.H., Hosking L.K., Shellard S.A., Bedford P., Lock R.B. Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitro. National Cancer Institute Monographs 1988; 6: 177–181
   Google Scholar
• Hong W.K., Dimery I.W., Kramer A.M., Paredes J., Robbins K.t., Campbell B. The role of induction chemotherapy in the treatment of advanced head and neck cancer. Adjuvant Therapy of Cancer, S.E. Salmon. Grune & Stratton, Orlando 1987; V: 79–87
   Google Scholar
• Hryniuk W.M., Bonadonna G., Valagussa P. The effect of dose intensity in adjuvant chemotherapy. Adjuvant Therapy of Cancer, S.E. Salmon. Grune & Stratton, Orlando 1987; V: 13–23
   Google Scholar
• Kies M.S., Mira J.G., Crowly J.J., Chen T.T., Pazur R., Grozea P.N., Rivkin S.E., Coltman C.A., Ward J.H., Livington R.B. A randomized study of induction combination chemotherapy with or without thoracic irradiation in compiete responders; and with wide field versus reduced-field radiation in partial responders. A South-West Oncology group study. Journal of Clinical Oncology 1987; 5: 592–600
   PubMed Web of Science ®Google Scholar
• Le Chevalier T., Arriagada R., De The H., De Cremoux H., Martin M., Baldeyrou P., Ruffie P., Benna F., Cerrina M.L., Sancho-Garnier H., Hayat M. Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients. National Cancer Institute Monographs 1988; 6: 335–338
   Google Scholar
• Looney W.B. Special lecture: alternating chemotherapy and radiotherapy. National Cancer Institute Monographys 1988; 6: 85–94
   Google Scholar
• Looney W.B., Hopkins H.A. Alternation of chemotherapy and radiotherapy in cancer management. III—Results in experimental solid tumors systems and their relationship to clinical studies. Cancer Treatment Reports 1986; 70: 141–162
   PubMedGoogle Scholar
• Louie K.G., Behrens B.C., Kinsella T.J., Hamilton T.C., Grotzinger K.R., McKoy W.M., Winker M.A., Ozols R.F. Radiation survival parameters of antineoplastic drug-sensitive and resistant human ovarian cancer cell lines and their modification by buthionine. Cancer Research 1985; 45: 2110–2115
   PubMed Web of Science ®Google Scholar
• Maase von der H. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumor. Radiotherapy and Oncology 1986; 7: 47–68
   PubMedGoogle Scholar
• Mandell L.R., Ghavimi F., Exelby P., Fuks Z. Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS). International Journal of Radiation Oncology, Biology and Physics 1988; 15: 197–203
   PubMed Web of Science ®Google Scholar
• Mitchell J.B., Gamson J., Russo A., Friedman N., De Graff W., Carmichaël J., Glatstein E. Chinese hamster pleiotropic multidrug resistant cells are not radioresistant. National Cancer Institute Monographs 1988; 6: 187–191
   Google Scholar
• Overgaard, M., Christensen, J.J., Johansen, H., et al. Post mastectomy irradiation in high risk breast cancer patients: present status of the Danish breast cancer cooperative trial. Acta Oncologica 1989, in press
   Google Scholar
• Ozols R.F., Cowan K. New aspects of clinical drug resistance in the role of gene amplification and the reversal of resistance in drug refractory cancer. Important Advances in Oncology, V.T. DeVita, S. Hellman, S.A. Rosenberg. J. B. Lippincott, Philadelphia 1987; 129–157
   Google Scholar
• Ozols R.F., Masuda H., Hamilton T.C. Keynote address: Mechanisms of cross-resistance between radiation and antineoplastic drugs. National Cancer Institute Monographs 1988; 6: 159–165
   Google Scholar
• Perry M.C., Eaton W.L., Propert K.J., Ware J.H., Zimmer B., Chahinian P., Skarin A., Carey R.W., Kreisman H., Faulkner C., Comis R., Green M.R. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. New England Journal of Medicine 1987; 316: 912–918
   PubMed Web of Science ®Google Scholar
• Rouesse J., Friedman S., Sarrazin D., Mouriesse H., Le Chevalier T., Arriagada R., Spielmann M., Papacharalambous A., May-Levin F. Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. Journal of Clinical Oncology 1986; 4: 1765–1771
   PubMed Web of Science ®Google Scholar
• Rubin P. Late effects of chemotherapy and radiation therapy: a new hypothesis. International Journal of Radiation Oncology, Biology and Physics 1984; 19: 5–34
   Google Scholar
• SECOG. A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. European Journal of Surgical Oncology 1986; 12: 289–295
   PubMedGoogle Scholar
• Schimke R.T. Methotrexate resistance and gene amplification. Mechanisms and implications. Accomplishments in Cancer Research, J.G. Fortner, J.E. Rhoads. J. B. Lippincott, Philadelphia 1986; 75–75
   Google Scholar
• Sklar M.D. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 1988; 239: 645–647
   PubMed Web of Science ®Google Scholar
• Steel G.C. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiotherapy and Oncology 1988; 11: 31–53
   PubMed Web of Science ®Google Scholar
• Tannock I.F., Browman G. Lack of evidence for role of chemotherapy in routine management of clinically advanced head and neck cancer. Journal of Clinical Oncology 1986; 4: 1121–1126
   PubMed Web of Science ®Google Scholar
• Taylor S.G. Why has so much chemotherapy done so little in head and neck cancer?. Journal of Clinical Oncology 1987; 5: 1–3
   PubMed Web of Science ®Google Scholar
• Tubiana M. Les associations radiothérapie-chimiothérapie. Bulletin du Cancer 1981; 68: 109–115
   PubMedGoogle Scholar
• Tubiana M. The growth and progression of human tumors. Implications for the management strategy. Radiotherapy and Oncology 1986; 6: 167–184
   PubMed Web of Science ®Google Scholar
• Tubiana M. Repopulation in human tumors. A biological background for fractionation in radiotherapy. Acta Oncologica 1988; 27: 83–88
   PubMed Web of Science ®Google Scholar
• Tubiana M., Sarrazin D. The role of post-operative radiotherapy in breast cancer. Breast Cancer. Diagnosis and Treatment, I.M. Ariel, J.B. Cleary. McGraw-Hill, New York 1987; 280–299
   Google Scholar
• Tubiana M., Arriagada R., Carde P., Cosset J.M., Le Chevalier T. Adjuvant radiotherapy in chemosensitive tumors. Adjuvant Therapy of Cancer, S.E. Salmon. Grune & Stratton, Orlando 1987; V: 25–34
   Google Scholar
• Tubiana M., Arriagada R., Cosset J.M. Sequencing of drugs and radiation. Cancer 1985; 55: 2131–2139
   PubMed Web of Science ®Google Scholar
• Tubiana M., Henry-Amar M., Hayat M., Burgers M., Qasim M., Somers R., Sizoo W., Vander Schueren E. The EORTC treatment of early stages Hodgkin's disease. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 197–210
   PubMed Web of Science ®Google Scholar
• Wallner K., Li G.C. Adriamycin resistance, heat resistance and radiation response in chinese hamster fibroblasts. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 829–833
   PubMed Web of Science ®Google Scholar
• Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica 1988; 27: 131–146
   PubMed Web of Science ®Google Scholar